论文部分内容阅读
在人口增长和人口结构变化以及生态环境和可持续发展等趋势面前,拜耳深知让一家医药行业的百年老店保持领先并获得新的动力源泉需要什么马尔金·戴克斯深知让一家医药行业的百年老店保持领先并获得新的动力源泉需要什么。对于下一个财年如何拉开与竞争对手的距离,身为拜耳集团管理董事会主席,马尔金·戴克斯和他的创新团队需要酝酿新的对策和动作。2012年11月14日,在位于勒沃库森拜耳总部举行的“2012年创新展望”新闻论坛上,马尔金·戴克斯表示,该公司2012年斥资大约30亿欧元用于研究和开发,
In the face of population growth and demographic changes, and ecological and sustainable trends, Bayer is well aware of the need to keep a century-old shop in the pharmaceutical industry ahead of new sources of motivation. Industry’s century-old to stay ahead of and get a new source of power what is needed. As the next fiscal year how to distance from competitors, as the Bayer Group’s management board chairman, Malkin Deck and his innovation team need to brew new strategies and actions. On 14 November 2012, at the “Innovations Outlook 2012” forum held at Bayer headquarters in Leverkusen, Mardin-Dex said the company spent about 3 billion euros in 2012 on research and development Development,